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The gene encoding the adenovirus type 2 IVa2 protein, a sequence-specific activator of transcription from the viral major
late promoter, is itself transcribed only during the late phase of infection. We previously identified a cellular protein (IVa2-RF)
that binds specifically to an intragenic sequence of the IVa2 transcription unit. We now report that precise substitutions within
the IVa2-RF-binding site that decreased binding affinity increased the efficiency of IVa2 transcription in in vitro reactions
containing IVa2-RF. Consistent with the conclusion that this cellular protein represses IVa2 transcription, mutations that led
to more efficient transcription in the presence of IVa2-RF were without effect in reactions lacking this cellular protein. No
change in the concentration or activity of IVa2-RF could be detected in adenovirus-infected cells during the period in which
the IVa2 gene is transcribed. We therefore propose that restriction of IVa2 transcription to the late phase is the result of
titration of this cellular repressor as the number of copies of the IVa2 promoter increases upon replication of the viral
genome. © 2000 Academic Press
Key Words: human adenovirus type 2; IVa2 promoter; IVa2 transcription; transcriptional repressor; repressor titration.
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GINTRODUCTION
A characteristic feature of the replication of human
subgroup C adenoviruses is the strict temporal regula-
tion of expression of viral genetic information. Prior to the
onset of viral DNA synthesis, nonstructural proteins that
are necessary for viral DNA synthesis, that regulate
various reactions in the production of viral mRNA, or that
counteract host defense mechanism are synthesized
(see Shenk, 1996). Proteins encoded within the immedi-
ate-early E1A transcription unit, which is transcribed by
the cellular RNA polymerase II transcriptional machinery
alone, are the first to be expressed in the infected cell
and are required for efficient transcription of viral early
genes (Berk et al., 1979; Jones and Shenk, 1979; Nevins,
981; see Berk, 1986; Shenk, 1996). The larger (289R) of
he two abundant E1A proteins stimulates transcription
f all viral early genes in infected cells (Berk et al., 1979;
ones and Shenk, 1979; Nevins, 1981) and can increase
he activity of a great variety of viral and cellular promot-
rs in experimental systems (see Jones, 1995; Shenk and
lint, 1991). The unique internal sequence of this protein,
hich contains the third of three sequences conserved
mong human adenoviruses, designated conserved re-
ions 1–3 (CR1–CR3) (Moran and Mathews, 1987), ap-
ears to operate via both cellular, sequence-specific
1 Current address: Department of Pediatrics, Cancer Center, Univer-
ity of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48105.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (609) 258-4575. E-mail: sjflint@molbio.princeton.edu.
397ranscriptional regulators (Flint and Jones, 1991; Liu and
reen, 1990) and components of the general initiation
achinery (Boyer et al., 1999; Chiang and Roeder, 1995;
eisberg et al., 1994, 1995; Lee et al., 1991; Mazzarelli et
al., 1997). The CR1 and CR2 sequences present in both
E1A proteins also regulate transcription. For example,
they mediate binding of E1A proteins to the cellular
retinoblastoma protein (Rb) to induce the release of
members of the E2F family of transcriptional activators
from association with Rb and thus transcription of E2F-
dependent genes, including several that are crucial for
progression from the G1 to the S phase of the cell cycle
(see Bartek et al., 1996; Flint and Shenk, 1997; Nevins,
1992; Weinberg, 1995), and the adenoviral E2 early pro-
moter (Kovesdi et al., 1986a,b; Manohar et al., 1990;
Zajchowski et al., 1985). Once E2 replication proteins
have accumulated to sufficient concentrations, viral DNA
synthesis begins within the infected cell nucleus. This
process not only produces the genomes that will be
incorporated into progeny virions, but also is crucial for
establishment of the transcriptional program character-
istic of the late phase of infection (see Flint, 1986; Shenk,
1996 for reviews). Although long recognized, the various
viral DNA replication-dependent changes in transcription
from the adenoviral genome have received relatively little
attention and remain incompletely understood.
During the late phase, the major late (ML) transcription
unit is transcribed to sites close to the right-hand end of
the linear, double-stranded viral DNA genome (Fraser et
al., 1979). In contrast, during the early phase, transcrip-
tion from the ML promoter terminates at multiple sites
0042-6822/00 $35.00
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398 LIN AND FLINTbetween about 40 and 75 map units (Akusja¨rvi and Per-
sson, 1981; Iwamoto et al., 1986; Nevins, 1981; Shaw and
iff, 1980). Coinfection experiments established that rep-
ication of the viral genome is a prerequisite for complete
ranscription of the ML transcription unit (Crossland and
askas, 1983; Thomas and Mathews, 1980). Indeed, the
roduction of replicated viral DNA molecules in the in-
ected cell may be sufficient (Larsson et al., 1992). This
equirement strongly suggests that some structural fea-
ure of the viral genome, or of the nucleoprotein in which
t resides during the early phase of infection, prevents
ranscription of the promoter-distal portion of the ML
ranscription unit. However, no direct support for this
odel has yet been collected. Run-on transcription as-
ays established that some 80% of transcription com-
lexes traversing the ML transcription unit fail to reach
he second exon and terminate transcription between
ositions 1190 and 11150 when synthesis of viral late
roteins is prevented (Larsson et al., 1992). The viral late
rotein(s) required for relief from such premature termi-
ation of transcription within the first ML intron has not
een identified, nor is it known whether replicated viral
NA templates are also necessary.
Entry into the last phase of infection also induces a
arge increase in the rate of transcription from the ML
romoter (Shaw and Ziff, 1980). Such stimulation of ML
ranscription in infected cells or in extracts prepared
rom them requires sequences within the first intron
Alonso-Caplen et al., 1988; Jansen-Durr et al., 1988,
989; Leong et al., 1990; Mansour et al., 1986; Mason et
l., 1990). The two intronic sequences primarily respon-
ible for stimulation of ML transcription, designated DE1
186 to 196) and DE2 (1113 to 1124), are specifically
ecognized by proteins present in adenovirus-infected
ells only during the late phase of infection (Jansen-Durr
t al., 1988, 1989; Leong et al., 1990; Monde´sert et al.,
992). The protein named DEF-A binds specifically to
E1 and with lower affinity to the 39 portion of the DE2
equence, whereas the infected cell-specific protein
ermed DEF-B interacts with the 59 segment of DE2
Jansen-Durr et al., 1989; Monde´sert et al., 1992).
edinger and colleagues identified the viral IVa2 protein
as the sole component of DEF-B and demonstrated that
DEF-A comprises the IVa2 protein in association with at
east one other infected cell-specific protein (Lutz and
edinger, 1996; Tribouley et al., 1994). Thus, in addition to
ts probable role in assembly (Gustin et al., 1996; Persson
t al., 1979; Winter and D’Halluin, 1991; Zhang and Impe-
iale, 2000), the adenoviral IVa2 protein is a sequence-
specific transcriptional activator. Its function as compo-
nents of both DEF-A and DEF-B accounts for the late-
phase-specific stimulation of ML transcription: IVa2
mRNA is not synthesized during the early phase of in-
fection (Binger and Flint, 1984; Chow et al., 1979; Cross-
land and Raskas, 1983; Winter and D’Halluin, 1991); the
DNA-binding activities of DEF-A or DEF-B cannot be
1detected until the IVa2 protein is synthesized (Lutz and
Kedinger, 1996), and production of IVa2 mRNA and pro-
tein precedes synthesis of ML mRNAs in the late phase
of infection (Binger and Flint, 1984; Winter and D’Halluin,
1991). On the other hand, the IVa2 promoter is one of
three in the adenoviral genome that are recognized only
following initiation of viral DNA synthesis (see Flint, 1986;
Shenk, 1996). As the activation of IVa2 transcription ap-
ears to be crucial for efficient production of viral struc-
ural proteins and successful completion of the infec-
ious cycle, the mechanism by which the activity of this
romoter is regulated during productive infection is of
onsiderable interest.
The initiation sites of the adenovirus type 2 (HAV-2)
Va2 and ML transcription units, which lie on opposite
strands of the viral genome, are separated by some 210
bp (Fig. 1). This arrangement of divergent transcription
units, in conjunction with results of in vitro transcription
and DNase I footprinting assays, led to the proposal that
the ML and the IVa2 promoters share binding sites for
SF/MLTF and thus compete for this transcriptional reg-
lator (Adami and Babiss, 1992; Carcamo et al., 1989;
oncollin et al., 1990; Natarajan et al., 1984). In principle,
uch competition could preclude IVa2 transcription dur-
ing the early phase of infection, when ML transcription is
stimulated by the 289R E1A protein (Leong et al., 1988;
evins, 1981). However, no increase in the production of
Va2 mRNA was observed in cells infected by viruses
arrying USF/MLTF-binding site mutations or additional
utations that impaired ML transcription (Reach et al.,
990), strongly arguing that competition for this (or any
ther) cellular protein is not an important mechanism of
egulation of the activity of the IVa2 promoter in infected
ells. Although the IVa2 promoter is not active until the
ate phase of adenovirus infection, it can be accurately
nd quite efficiently recognized by the cellular transcrip-
ional machinery under specific in vitro conditions (Kasai
t al., 1992; Leong and Flint, 1984; Matsui, 1982; Natara-
an et al., 1983, 1984). Such transcription requires an
utonomous initiator sequence that directs transcription
rom the major start site observed in infected cells and
n intragenic sequence essential for efficient transcrip-
ion (Carcamo et al., 1991; Chen and Flint, 1992; Kasai et
l., 1992). A binding site for a cellular protein centered at
osition 247 of the transcription unit stimulates IVa2
transcription in vitro, but by only a modest degree (Kasai
t al., 1992; Natarajan et al., 1984; Natarajan and Salz-
an, 1985). The mechanism of recognition of the IVa2
promoter, which lacks a TATA sequence (Chen and Flint,
992), has not been elucidated, although all RNA poly-
erase II general initiation proteins are necessary (Car-
amo et al., 1989). In previous studies, we identified a
ellular protein that binds specifically to intragenic IVa2
sequences, making contacts between positions 111 and
27 (Chen et al., 1994). As preliminary analyses sug-
gested that binding of this protein correlated with inhibi-
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399A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONtion of IVa2 transcription, the protein was designated
Va2-repressing factor (IVa2-RF). The presence of a re-
ressor of IVa2 transcription in HeLa cells could readily
account for the inactivity of the promoter during the early
phase of infection. We have therefore investigated in
more detail the role of this cellular protein in transcrip-
tion from the IVa2 promoter and determined the effects of
denovirus infection upon its activity.
RESULTS
utations of intragenic IVa2 promoter sequences that
mpair binding of a cellular protein
Our previous conclusion that binding of the cellular
Va2-RF protein to intragenic promoter sequences inhib-
ts IVa2 transcription (see Introduction) was based on
nalysis of the effects of a minimal number of promoter
utations. As the IVa2 sequence from positions 24 and
30 is packed with transcriptional control signals, which
ppear to overlap (Chen and Flint, 1992; Chen et al.,
994; Fig. 1), a more extensive mutational analysis was
nitially undertaken to confirm the function of IVa2-RF in
egulation of the activity of the IVa2 promoter. A series of
precise substitutions between positions 110 and 120 of
he viral transcription unit was introduced into both plas-
id templates for IVa2 transcription in vitro and double-
stranded oligonucleotides containing the IVa2-RF binding
site, as described under Materials and Methods. The
location of these mutations was chosen to attempt to
avoid alteration of the previously identified, downstream
sequence essential for efficient initiation of transcription
from the IVa2 initiator element, upon which the binding
ite for IVa2-RF is superimposed (Fig. 1; Chen et al.,
FIG. 1. Organization of the subgroup C adenovirus IVa2 promoter. The
transcription units is represented to scale by the solid, horizontal lines
the direction of transcription. The positions of these ML and IVa2 initia
IVa2 promoter, with the major and minor initiation sites shown by solid
equences shown, an initiator (InR), the intragenic sequence essen
equence (247) that stimulates IVa2 transcription by a factor of 3–5 wer
nd Flint, 1992; Chen et al., 1994; Kasai et al., 1992). The oval indicate
l., 1994).994). Another consideration important to the goal of
nvestigating regulation of IVa2 transcription during pro- 5uctive infection was the effects of the substitutions on
he coding sequence for the viral DNA polymerase,
ithin which the IVa2 promoter lies (Fig. 2). The effects of
he mutations on recognition of its intragenic binding site
y IVa2-RF were examined using electrophoretic mobility
hift assays with wild-type and mutant DNA fragments as
ompetitors. A single complex sensitive to competition
y unlabeled IVa2 DNA, but refractory to competition by
n unrelated viral DNA fragment, was observed when
he partially purified protein was incubated with a 32P-
abeled DNA fragment comprising position 12 to 135 of
he IVa2 promoter (Fig. 3A, lanes 1–9). The mutations
listed in Fig. 2 reduced the ability of unlabeled DNA
fragments to compete for such specific binding of par-
tially purified IVa2-RF to the wild-type IVa2 sequence (e.g.,
ig. 2A, lanes 10–26). The inhibition of binding induced
y these substitutions was not surprising, as this region
f the IVa2 transcription unit is contacted on both DNA
strands by the cellular protein (Chen et al., 1994). In an
attempt to distinguish sequence features important for
binding of IVa2-RF, the effects of the mutations were
assessed more quantitatively. The quantities of specific
complex formed in the presence of increasing concen-
trations of each mutant competitor, or of the wild-type
sequence, were measured using a phosphorimager. The
concentrations of competitor required to inhibit binding
to the wild-type IVa2 DNA fragment by 50% were then
determined from plots like those shown in Fig. 3B and
used to calculate the affinities with which the cellular
protein bound to each mutant DNA relative to that for
binding to the wild-type promoter (Fig. 2).
The substitutions could be divided into two classes by
the criterion of whether they reduced the affinity of
ent of the viral DNA genome containing the 59 ends of the IVa2 and ML
op, with sites of transcriptional initiation indicated by arrows drawn in
es in the genome (bp) are listed at the top. The region containing the
ashed arrows, respectively, is expanded at the bottom. The promoter
efficient, initiator-dependent transcription (DSE-s), and an upstream
ified by mutational analyses using in vitro transcription reactions (Chen
tragenic sequence contacted by the cellular protein IVa2-RF (Chen etsegm
at the t
tion sit
and d
tial for
e identIVa2-RF for the internal promoter sequence by a factor of
–10 or were significantly more deleterious (Figs. 2 and
A
y
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o
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400 LIN AND FLINT3B). Comparison of the sequences altered in the mem-
bers of the two classes of mutation indicated that this
protein can tolerate some surprisingly extensive
changes in its binding site. For example, substitution of
the 7 consecutive basepairs occupying positions 110 to
116, as in the Rep5 mutant, reduced binding by only
some 10-fold (Fig. 2). Nevertheless, certain basepair sub-
stitutions within the IVa2-RF binding site severely im-
paired its recognition. Three of four altered sequences to
which the protein bound with greatly reduced affinity,
Rep1, Rep4, and Rep7, contain a CG pair in place of the
TA pair at position 116 of the wild-type sequence (Fig. 2).
FIG. 2. Design and properties of mutations within the negative regul
sequence, which includes the intragenic promoter sequences shown in
encoding the viral DNA polymerase in the l strand of the HAV-2 genome
strand of the IVa2 transcription unit is given below, arranged to show the
of this sequence, the amino acids they specify. The sequences from po
the changes, if any, introduced into the DNA polymerase coding seque
type. The effects of these mutations on the affinity with which IVa2-RF
f wild-type or mutant IVa2 DNA fragments required for 50% inhibition
illustrated in Fig. 3. These values were then used to calculate the affini
inding to the wild-type promoter assigned a value of 1.0.Because the only other alteration introduced into the
Rep7 mutant, substitution of a CG for an AT basepair at
r
iposition 119, was also present in mutated sequences to
which IVa2-RF bound relatively well, such as Rep6 (Figs.
2 and 3), we can conclude that introduction of a CG
basepair at position 116 severely impairs binding of the
protein. Such inhibition of binding does not appear to be
the result of loss of a specific base contact, for the A in
the noncoding strand at position 116 is not contacted by
IVa2-RF (Chen et al., 1994). However, it is adjacent to an
at position 115 in the noncoding strand, whose meth-
lation enhanced binding of the protein (Chen et al.,
994). Furthermore, a GC rather than a CG basepair at
his position, as in Rep6, Rep3, Rep8, and Rep5 DNAs,
equence of the IVa2 promoter. The position of the IVa2 59 untranslated
and coding sequence relative to that of the overlapping reading frame
wn to scale at the top. The sequence of the first 25 bases of the coding
s of the DNA polymerase reading frame and, for the four central codons
8 to position 119 of 8 precise substitution mutations, Rep1–Rep8, and
e listed below, with altered bases and amino acids shown in boldface
o DNA are summarized at the right. The molar excess concentrations
ing of the protein to the wild-type IVa2 sequence were determined as
binding of IVa2-RF to the eight mutant sequences, relative to that of itsatory s
Fig. 1,
is sho
codon
sition 1
nce, ar
binds t
of bindesulted in a much smaller degree of inhibition of bind-
ng, regardless of the nature and number of other sub-
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401A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONstitutions present in these mutant DNAs (Figs. 2 and 3).
These observations suggest that the conformation of the
DNA sequence with which IVa2-RF interacts, or its con-
FIG. 3. Intragenic substitutions impair binding of IVa2-RF to the IVa2
partially purified IVa2-RF were performed as described under Materials
olar excess concentrations indicated of the unlabeled wild-type or m
mutated version of the ML sequence 180 to 1120 (NS), listed at the t
right. Lanes 1–13 and 14–26 represent two gels run in parallel. The m
2. Quantification of inhibition of IVa2-RF binding as a function of competi
three independent assays.ormational deformability, is an important determinant of
pecific binding of the protein to the IVa2 promoter. Ad-
pitional experiments will be required to test this possi-
ility more directly, as well as to assess the contributions
f individual base contacts made by the protein between
ter to different degrees. Electrophoretic mobility shift assays (A) with
ethods. Binding reactions contained no competitor DNA (lane 1) or the
IVa2 DNA fragments, or of an unrelated DNA fragment containing a
specific complex containing IVa2-RF is indicated by the arrow at the
s present in the Rep3, Rep6, Rep7, and Rep8 DNAs are shown in Fig.
centration is illustrated in B. Each point represents the mean of at leastpromo
and M
utated
op. The
utationositions 111 and 127 (Chen et al., 1994) to the IVa2-
RF–DNA interaction.
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402 LIN AND FLINTEffects of the Rep substitutions on IVa2 promoter
activity
Our previous analyses of intragenic sequences con-
tributing to the IVa2 promoter relied on minimal promot-
ers, for example, comprising the HAV-2 IVa2 sequence
from position 29 to position 131 (Chen and Flint, 1992;
Chen et al., 1994). To provide a less artificial background,
the substitutions described in the previous section were
introduced into the IVa2 promoter in the context of a
arger segment of the viral genome, which included the
ntergenic sequence between the IVa2 and ML transcrip-
ion units, the 59 ends of both viral transcription units,
nd hence the ML promoter. The wild-type and mutant
emplates were transcribed in whole-cell extracts pre-
ared from uninfected HeLa cells as described, and the
uantities of IVa2 and ML transcripts and the sites at
hich transcription initiated were then determined by
rimer extension with appropriate primers (see Materials
nd Methods). A ML promoter lacking all sequences
FIG. 4. Alterations in IVa2 and ML transcription by whole cell extrac
escribed under Materials and Methods and contained the pML(C2AT)D
the Rep3, Rep6, Rep7, or Rep8 mutant templates (lanes 3–6). End-labe
The positions of cDNAs copied from IVa2 and ML transcripts of pIVa2-M
(trans-ML) are indicated at the right, and the lengths of DNA markers ar
easured and corrected using the internal control transcript, as descr
nternal control template and the wild-type pIVa2-ML template (lane
End-labeled DNA markers (lane 1) and positions of IVa2 and cis- and
initiated at altered sites are indicated by asterisks at the right.pstream of position 250 (and therefore the binding site
or IVa2-RF) (see below) linked to a G-less cassetteSawadogo and Roeder, 1985a) was used as an internal
ontrol. Representative results are shown in Fig. 4.
Although all the Rep substitutions impaired binding of
Va2-RF to the IVa2 promoter (Figs. 2 and 3), their effects
on IVa2 transcription were not uniform. Four of the mu-
ations, Rep3, Rep6, Rep7, and Rep8, increased the effi-
iency of IVa2 transcription (Fig. 4A). The degree of tran-
criptional stimulation correlated with reduction in affin-
ty of the cellular protein for its internal binding site in the
Va2 promoter: the Rep7 mutation, which resulted in a
reduction of binding affinity of over 30-fold (Figs. 2 and 3),
increased the efficiency of IVa2 transcription by a factor
f close to 5 (Fig. 4A, compare lanes 2 and 5), whereas
he Rep3, Rep6, and Rep8 substitutions reduced the
ffinity of IVa2-RF for the IVa2 promoter less than 10-fold
(Figs. 2 and 3) and stimulated transcription by factors of
some 1.5–3 (Fig. 4A, lanes 3, 4, and 6). The efficiency of
transcription from the IVa2 promoter in HeLa cell extracts
is critically dependent on the ratio of extract protein to
ns induced by the Rep mutations. (A) Transcription reactions were as
ternal control template and the wild-type pIVa2-ML template (lane 2) or
III fragments of pBR322 DNA used as markers were loaded in lane 1.
lates (IVa2 and cis-ML, respectively) and the internal control template
n at the left. The relative concentrations of IVa2 transcripts shown were
der Materials and Methods. (B) Transcription reactions contained the
he Rep1, Rep2, Rep3, Rep4, or Rep5 mutant templates (lanes 3–7).
L transcripts are indicated as in A. Transcripts of mutant templatest protei
-50 in
led Hae
L temp
e show
ibed un
2) or ttemplate DNA concentrations, decreasing sharply as the
protein concentration is increased above a narrow range
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403A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONof optimal values (Leong and Flint, 1984). Consequently,
all our studies of the sequences that form the IVa2 pro-
moter have been performed under conditions that sup-
port efficient transcription from this promoter. The use of
conditions chosen to reduce such inhibitory effects, as
well as the complex organization of the IVa2 promoter
(see Introduction), undoubtedly accounts for the fact that
the inverse correlation between binding of IVa2-RF and
efficiency of IVa2 transcription observed with the set of
mutant templates is relative, rather than numerically ab-
solute.
Unexpectedly, these mutations also led to more effi-
cient transcription from the viral ML promoter present in
cis in the same template (Fig. 4A). This effect was repro-
ducible and also characteristic of the templates carrying
additional Rep mutations described in the previous sec-
tion (e.g., Fig. 4B, compare lanes 2–5). These results
indicate that binding of IVa2-RF to the IVa2 promoter
mpairs ML transcription, even though the sequence
ecognized by this protein lies some 220 bp upstream of
he site of initiation of ML transcription (Fig. 1).
Some of the Rep mutations altered the specificity of
nitiation of IVa2 transcription, inducing initiation at new
ites 7–12 bp downstream of position 11 (Rep2, Rep3,
nd Rep5; Fig. 4B, lanes 2, 4, 5, and 7) and/or more subtle
lterations in the frequency of utilization of initiation sites
n the vicinity of those recognized in the wild-type pro-
oter (Rep1, Rep4, and Rep5; Fig. 4B, lanes 2, 3, 6, and
). All members of this set of mutant templates include
ubstitutions of positions 110 and 111, whereas the
utations that stimulated IVa2 transcription with no
hanges in initiation specificity (Rep6, Rep7, and Rep8)
id not (Figs. 2 and 4). As these substitutions did not
reate a sequence common to the mutant templates in
he vicinity of the downstream initiation sites (Fig. 2), it
ppears that the IVa2 initiator extends to at least position
11 of the transcription unit. It seems unlikely that this
omponent of the promoter extends further downstream
y more than a few basepairs, for limited or extensive
ubstitutions between positions 114 and 119 did not
lter initiation specificity (Fig. 4A; Chen et al., 1994). In
ddition, the sequence spanning positions 29 to 113 is
ufficient to direct specific initiation of IVa2 transcription
(Carcamo et al., 1991; Chen and Flint, 1992). The substi-
tutions that impinged upon the IVa2 initiator sequence
resulted in at best modest stimulation of transcription
(Fig. 4B), even though they inhibited binding of IVa2-RF to
the IVa2 promoter (Figs. 2 and 3). We therefore conclude
hat relief from repression of transcription resulting from
mpaired binding of this cellular protein to the promoter
ust be offset by unfavorable changes in the initiator or
n the downstream sequence required for efficient IVa2
transcription (Fig. 1).
To provide additional support for the interpretations ofthe effects of the Rep mutations on IVa2 transcription
given in the previous paragraphs, we sought to separate
s
tthe cellular proteins mediating IVa2 transcription from
IVa2-RF. The latter protein elutes from heparin–agarose
t relatively low ionic strength (Chen et al., 1994),
hereas the basal RNA polymerase II transcriptional
achinery has been reported to require a much higher
alt concentration (Dynan and Tjian, 1983). We therefore
ractionated HeLa whole-cell-extract proteins on this ma-
rix and examined the ability of fractions recovered to
upport or alter IVa2 transcription. The proteins recov-
ered between 0.18 and 1.0 M KCl allowed initiation of
transcription from the IVa2 promoter, the wild-type ML
romoter present in the same DNA template, and the
runcated ML promoter described above, but at consid-
rably lower efficiencies than observed when whole-cell-
xtract proteins were supplied (Fig. 5A, compare lanes 2
nd 3). The substantial reduction in transcription from all
hree promoters suggests that essential transcriptional
omponents were diluted below a threshold concentra-
ion needed for efficient activity during fractionation.
owever, we cannot exclude the possibility that proteins
pecifically required for IVa2 transcription were not re-
covered in the 1.0 M KCl heparin–agarose fraction, for
utilization of the minor IVa2 initiation site at position 22
was selectively impaired in reactions containing this
fraction (Fig. 5A, lanes 2 and 3). Such different require-
ments for initiation from the major (11) and minor (22)
sites are consistent with our previous observation that
the 29 to 113 initiator specifies only the major site
(Chen and Flint, 1992). Mutations that resulted in more
efficient IVa2 and ML transcription by whole-cell-extract
roteins (Fig. 4A) were without significant effect when
he templates were transcribed in reactions containing
he 1.0 M KCl fraction (e.g., Fig. 5A, lanes 3–6). As this
raction contained no IVa2-RF activity that could be de-
ected by the electrophoretic mobility shift assay de-
cribed previously (data not shown), this difference in
roperties of the mutant templates provides additional
upport for the conclusion that the stimulation of IVa2
transcription in whole-cell extracts induced by the muta-
tions is a direct result of impaired binding of the IVa2-RF
to the promoter.
Addition of the IVa2-RF-containing heparin–agarose
fraction to transcription reactions containing basal tran-
scription components further reduced IVa2 transcription
rom the wild-type promoter, but inhibited transcription
rom derivatives carrying substitutions that impaired
inding of the cellular protein, such as the Rep6 and
ep7 templates, to a lesser degree (data not shown).
imilar results were obtained with the synthetic IVa2
promoter pIVTnR-TC described previously (Chen et al.,
1994) and a mutated version to which IVa2-RF binds less
fficiently. However, the high background observed
hen the transcriptional machinery was supplied in the
.0 M KCl heparin–agarose eluate, the consequent low
ignal:noise ratios, and particularly the very inefficient
ranscription of the internal control template (e.g., Fig. 5A,
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404 LIN AND FLINTlanes 3–6) precluded reliable quantitative comparisons
among the responses of the wild-type and mutated IVa2
promoters to the addition of partially purified IVa2-RF.
hese limitations prompted us to examine the effects of
ddition of the partially purified protein to transcription
eactions containing whole-cell-extract proteins. As the
oncentration of the IVa2-RF-containing fraction added to
uch reactions was increased, transcription from the IVa2
promoter was reduced by a factor of over 20 (Fig. 5B,
lanes 2–4). ML transcription from the same template
DNA was similarly inhibited (Fig. 5B, lanes 2–4), to a
relative value of 0.04 at the highest concentration of
IVa2-RF examined. Such inhibition was a specific conse-
uence of binding of IVa2-RF to the template, for tran-
cription from the internal control template that lacks the
inding site for this cellular protein was not altered (Fig.
B, lanes 2–4 and 5–7). Furthermore, neither IVa2 nor ML
transcription was impaired when the same concentra-
tions of IVa2-RF were added to reactions containing the
ep6 mutant template (Fig. 5B, lanes 5–7), to which this
rotein cannot bind efficiently (Figs. 2 and 3). In toto, the
xperiments described in this section establish that
FIG. 5. Transcription from wild-type and mutated IVa2 promoters in th
internal control pML(C2AT)D-50 template and the wild-type pIVa2-ML te
–6, respectively), and 6 mg/ml whole HeLa cell extract protein (lane
recovered upon chromatography of such extracts on heparin–agarose (
the pML(C2AT)D-50 internal control template and the wild-type (lanes 2–
and 0 (lanes 2 and 5), 0.8 (lanes 3 and 6), or 1.6 (lanes 4 and 7) mg p
Methods). The concentrations of IVa2 transcripts relative to that of those
fraction, measured as described under Materials and Methods, are ind
from IVa2, ML, and internal control (trans-ML) transcripts are indicated
left.inding of the cellular protein dubbed IVa2-RF to its
recognition site within this viral transcription unit re-presses IVa2 transcription, as well as transcription from a
cis-ML promoter.
Effects of HAV-2-infection on the activity of IVa2-RF
The identification of a cellular protein that represses
ranscription upon binding to the adenoviral IVa2 pro-
moter immediately suggests mechanisms accounting for
the late-phase-specific transcription of the IVa2 gene
observed in infected cells (see Introduction). For exam-
ple, little IVa2 transcription is observed in HeLa cell
extracts under conditions that support efficient transcrip-
tion from other promoters (Leong and Flint, 1984) and this
adenoviral promoter is inactive in transient expression
assays unless linked to the powerful SV40 enhancer
(Natarajan and Salzman, 1985). It therefore seems likely
that the concentration of IVa2-RF in host cells and its
affinity for the binding site in the IVa2 transcription unit
are sufficient to maintain this promoter in an inactive
state during the early phase of infection. The “activation”
of IVa2 transcription as the infectious cycle enters the
late phase would then, in fact, result from relief of such
transcriptional repression, for example by virus-induced
nce and presence of IVa2-RF. (A) Transcription reactions contained the
(lanes 2 and 3) or the Rep3, Pep6, or Rep7 mutant derivatives (lanes
0.38 mg/ml protein of the 1.0 M KCl eluate that contains no IVa2-RF,
terials and Methods) (lanes 3–6). (B) Transcription reactions contained
p6 (lanes 5–7) pIVa2-ML templates, 6 mg/ml whole-cell extract protein,
f the heparin–agarose fraction containing IVa2-RF (see Materials and
rom the wild-type promoter in the absence of added IVa2-RF-containing
below each lane. In both panels, the positions of cDNAs synthesized
ight, and the lengths of DNA markers loaded in lane 1 are listed at thee abse
mplate
2) or
see Ma
4) or Re
rotein o
made f
icatedalterations in the synthesis, stability, or activity of the
protein(s) that comprises IVa2-RF. To investigate whether
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405A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONthe production or activity of the protein is indeed modu-
lated as the viral infectious cycle progresses, we com-
pared IVa2 transcription in extracts prepared from in-
ected or uninfected cells.
Whole-cell extracts were prepared in parallel from
ninfected HeLa cells and cells harvested 12–16 h after
AV-2 infection, when IVa2 transcription is in full swing
(see Introduction). The abilities of these extracts to sup-
port transcription from a minimal IVa2 promoter compris-
ng sequences from 29 to 131 and from a derivative
arrying an intragenic substitution in the IVa2-RF-binding
ite (pIVTnR-TC and pIVa2-dsm2, respectively; Chen and
lint, 1992; Chen et al., 1994) were then compared, using
primer complementary to sequences of the neomycin-
esistance gene located downstream of the viral pro-
oter to distinguish transcripts synthesized in vitro from
Va2 RNA recovered in infected cell extracts. No increase
in the efficiency of transcription from the wild-type pro-
moter was observed in infected cell extracts (Fig. 6A,
compare lanes 1 and 4), the result predicted if the con-
centration of IVa2-RF were reduced, or its activity inhib-
ted, in adenovirus-infected cells. Such a lack of effect
annot be ascribed to the minimal nature of the IVa2
FIG. 6. HAV-2 infection does not alter IVa2-RF activity. (A) Transcriptio
and 4), its mutated derivative pIVa2-dsm2 (lanes 2 and 5) to which IVa
he ML promoters (lanes 3 and 6) (see Chen and Flint, 1992) and 5.6 m
ells harvested 16 h after infection with 15 PFU/cell HAV-2 (lanes 4–6
ocated downstream of the IVa2 sequences (Chen and Flint, 1992) was
resent in the infected cell extracts. The positions of the cDNAs copie
he pIVInR-TC series (lanes 1, 2, 4, and 5) fail to direct initiation from the
nder Materials and Methods, except that they contained 1.0 mg poly(dI
prepared in parallel from uninfected (lanes 1 to 5) or HAV-2-infected (l
to add proteins extracted from equal numbers of infected and uninfec
infected whole-cell extracts added to reactions were 1.23 and 1.34 mg
ndicated by the arrow at the right.promoter, for a wild-type IVa2 promoter that retained all
upstream sequence to position 2258 (including a cis-ML
m
spromoter) was also transcribed with indistinguishable
efficiencies in uninfected and HAV-2-infected HeLa cell
extracts (Fig. 6A, compare lanes 3 and 6). Furthermore,
the dsm2 mutation that impairs binding of IVa2-RF to the
IVa2 promoter (Chen et al., 1994) induced a similar de-
gree of stimulation of IVa2 transcription in the uninfected
and infected cell extracts (Fig. 6A, lanes 2 and 5). These
results indicate that HAV-2 infection does not lead to any
significant change in the concentration or activity of
IVa2-RF during the period in which the IVa2 gene is
ranscribed. To confirm this conclusion, the DNA-binding
ctivity of the cellular protein recovered in uninfected
nd infected cell extracts was examined directly, using
he electrophoretic mobility shift assay described in a
revious section. As illustrated in Fig. 6B, no decrease in
he DNA-binding activity of IVa2-RF could be detected by
he late phase of infection.
DISCUSSION
Previous studies established that the short sequence
panning the 59 end of the adenoviral IVa2 transcription
nit is functionally complex, including sequences that
ions contained 15 mg/ml of the synthetic IVa2 template pIVInr-TC (lanes
ds poorly, or the pIVa2-258/148 template containing both the IVa2 and
ole-cell extract protein from uninfected HeLa cells (lanes 1–3) or from
mer complementary to a sequence of the neomycin-resistance gene
distinguish IVa2 transcripts made in vitro from endogenous viral RNA
the RNAs transcribed in vitro are indicated at the right. Templates of
e (Chen and Flint, 1992). (B) DNA-binding reactions were as described
(dI z dC) and increasing volumes (from 1 to 10 ml) of whole-cell extracts
to 10) HeLa cells. This method of comparison was chosen to attempt
lls to the reactions. The protein concentrations of the uninfected and
spectively. The position of the specific complex containing IVa2-RF isn react
2-RF bin
g/ml wh
). A pri
used to
d from
22 sit
z dC) z
anes 6
ted ceodulate the efficiency of transcription from an initiator
equence both positively and negatively (Carcamo et al.,
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406 LIN AND FLINT1991; Chen and Flint, 1992; Chen et al., 1994). Although
the typical set of RNA polymerase II initiation proteins
has been shown to be required for transcription from this
TATA sequence-lacking promoter (Carcamo et al., 1989),
only one cellular protein that binds specifically to the IVa2
promoter has been identified to date (Chen et al., 1994).
This human (HeLa cell) protein, designated IVa2-RF, con-
tacts specific bases in both strands of the DNA between
positions 111 and 127 of the transcription unit. Several
lines of evidence reported here establish unequivocally
that this protein is a sequence-specific repressor of
transcription from this viral late promoter; the effects of
the substitution mutations Rep3, Rep6, Rep7, and Rep8
introduced between positions 110 and 120 on the rel-
ative affinity with which IVa2-RF binds to the intragenic
romoter sequence correlated inversely with the effi-
iency of IVa2 transcription in HeLa cell extracts (Figs. 2,
3, and 4); these same mutations did not induce any
stimulation of IVa2 transcription when transcriptional
omponents were supplied in a fraction lacking IVa2-RF
(Fig. 5A) and increasing the concentration of the latter
protein relative to that of the general transcriptional ma-
chinery inhibited transcription from the wild-type pro-
moter, but not from a promoter carrying a mutation that
impaired its recognition by IVa2-RF (Fig. 5B).
The binding site for IVa2-RF defined by methylation
nterference assays extends into the intragenic se-
uence required for efficient initiation of transcription
rom the IVa2 promoter (Fig. 1). The results presented
here indicate that this binding site is also superimposed
on the IVa2 initiator element. As described previously, the
ltered specificity of initiation of IVa2 transcription in-
uced by several of the Rep mutations (Fig. 4) indicates
hat the initiator extends to position 111, a basepair
contacted by IVa2-RF in the wild-type promoter (Chen et
al., 1994). The extent to which the repressor-binding site
overlaps both the initiator and the downstream stimula-
tory sequences of the promoter remains to be precisely
determined. Nevertheless, the superimposition of the
IVa2-RF binding site on these promoter sequences evi-
ent from the data currently available suggests an obvi-
us mechanism for inhibition of transcription by this
rotein: its binding to the promoter may block access of
eneral initiation proteins and RNA polymerase II to the
nitiator and downstream promoter sequence (Fig. 1) and
hus assembly of preinitiation complexes. Interference
ith recognition of both of the sequences required for
fficient and accurate initiation of IVa2 transcription
would appear to be an effective mechanism of repres-
sion. However, the unexpected ability of binding of
IVa2-RF to the IVa2 promoter to inhibit transcription from
he ML promoter (Fig. 4) strongly argues that this protein
an interfere with RNA polymerase II transcription by a
ore active mechanism. The binding site for the repres-or is located over 200 bp away from the ML initiation
ite (Fig. 1), and it does not lie upon any binding sites forellular proteins required for efficient ML transcription in
itro or in adenovirus-infected cells (Chodosh et al., 1986;
iyamoto et al., 1985; Reach et al., 1990; Sawadogo and
Roeder, 1985b). Thus, it appears that IVa2-RF bound to
he IVa2 promoter must interfere with ML transcription by
making contact with one or more of the proteins that
mediate or stimulate transcription from this promoter.
As noted previously, the presence of a sequence-
specific repressor of IVa2 transcription in human cells
can readily account for the lack of transcription from this
promoter during the early phase of infection. We ob-
tained no evidence for inactivation or degradation of this
cellular protein by the period in the infectious cycle in
which IVa2 transcription takes place (Fig. 6). We therefore
suggest that initiation of IVa2 transcription in the late
hase of the infectious cycle is a direct consequence of
he rapid and large increase in the concentration of IVa2
promoter sequences, following the onset of viral DNA
synthesis. During this period, the number of copies of the
IVa2 promoter and IVa2-RF-binding site increases rapidly,
while the concentration and activity of IVa2-RF do not
hange significantly (Fig. 6). Thus, above some threshold
alue determined by the intranuclear concentration of
he repressor and its affinity for the binding site in the
Va2 promoter, the infected cell would contain a greater
umber of IVa2 promoters than could be bound by IVa2-
RF. Consequently, some copies would remain repressor-
free, allowing IVa2 transcription to begin (Fig. 7). While
this model for the temporal regulation of IVa2 transcrip-
tion during adenovirus infection is consistent with the
results of the in vitro experiments described here, as well
as the exquisite sensitivity of IVa2 transcription to extract
rotein:DNA ratio (Leong and Flint, 1984), it will be nec-
ssary to examine the effects of mutations that impair
inding of IVa2-RF to the promoter upon the kinetics and
efficiency of IVa2 transcription in infected cells. This
pproach is complicated by both the intricate organiza-
ion of the IVa2 promoter and the inclusion of this pro-
oter in the coding sequence for the viral DNA polymer-
se (Fig. 2), a protein essential for virus reproduction
Roovers et al., 1991). Nevertheless, these in vitro studies
have identified IVa2 promoter mutations with appropriate
roperties, notably the Rep7 mutation, which substan-
ially impairs binding of IVa2-RF (Figs. 2 and 3) and
nduces an increase in the efficiency of IVa2 transcription
in vitro (Fig. 4), but does not alter the primary sequence
of the viral DNA polymerase (Fig. 2).
The adenoviral protein IX (pIX) and E2 late (E2L) pro-
moters are also recognized in infected cells only after the
transition into the late phase of infection (see Flint, 1986;
Shenk, 1996). As discussed below, two mechanisms me-
diating temporal regulation of transcription of the pIX
gene have been identified, but nothing is known about
control of transcription from the E2L promoter, which
eventually directs production of the vast majority of E2
transcripts made in the infected cell (Chow et al., 1979).
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407A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONA search of the subgroup C adenoviral genome for po-
tential binding sites for IVa2-RF, using the 111 to 127
sequence of the IVa2 promoter contacted by this protein
(Chen et al., 1994), revealed only one related sequence.
This sequence, which is identical at 13/17 positions to
the IVa2-RF-binding site of the IVa2 transcription unit, lies
some 300 bp upstream of the initiation site of the E2L
promoter. The presence of so close a match to such a
relatively long binding site in the vicinity of this late
promoter seems unlikely to be fortuitous. It will therefore
be of considerable interest to determine whether IVa2-RF
lso contributes to the late-phase-specific activity of the
2L promoter.
The mechanism of viral DNA synthesis-dependent an-
i-repression proposed for temporal regulation of IVa2
transcription during the adenoviral infectious cycle (Fig.
7) has a precedent in other viral systems. In particular,
Mertz and colleagues have demonstrated that transcrip-
tion from the most frequently used of the multiple sites of
initiation of SV40 late transcription is repressed by bind-
ing at multiple sites of a cellular protein (IBP) containing
the hERR1 member of the steroid-thyroid receptor super-
family and that mutation of such binding sites leads to
stimulation of late transcription during the early phase
following transfection of viral genomes into permissive
monkey cells (Wiley et al., 1993). A cellular repressor of
transcription of the subgroup C adenovirus late protein IX
FIG. 7. Model for temporal regulation of IVa2 transcription, as a
oncentration of this promoter. The IVa2 transcriptional control regiongene has also been identified: the human RBP-2N pro-
tein binds specifically to a sequence located immedi-
Tately upstream of the TATA sequence of the pIX transcrip-
tion unit and mutation of this sequence leads to in-
creased production of pIX mRNA during the early, but not
the late, phase of infection (Dou et al., 1994). The pIX
gene lies entirely within the E1B transcription unit, and
relief from promoter occlusion imposed by transcription
from the E1B promoter, which is active during the early
phase of infection, has also been implicated in the acti-
vation of pIX transcription following viral DNA synthesis
(Vales and Darnell, 1989). Although the identity of the
protein(s) that comprise(s) IVa2-RF is not yet known, the
NA sequence it recognizes is not related to the binding
ites for either of the human IBP or RBP-2N proteins
mplicated in repression of transcription from other viral
ate promoters. It therefore appears that the simpler DNA
iruses that replicate in primate cells have evolved
echanisms for temporal regulation of transcription of
iral late genes that depend on a variety of cellular
epressors of transcription.
The repressor titration mechanism for DNA replica-
ion-dependent activation of transcription of viral late
enes offers the advantage of coupling production of
rogeny viral genomes in the infected cell with synthesis
f the structural proteins from which virions will be as-
embled. In the case of SV40, such coupling is direct, for
he single late transcription unit contains the coding
equence for all three capsid proteins (see Griffin, 1980).
of the viral DNA replication-dependent increase in the intranuclear
cellular IVa2-RF protein are depicted as in Fig. 1.he cellular IVa2-RF protein may also inhibit transcription
from the adenoviral ML promoter during the early phase
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408 LIN AND FLINTof infection. However, the ML is as active as other early
promoters prior to viral DNA synthesis (Shaw and Ziff,
1980). Thus, during adenovirus infection, such coupling
appears to be largely indirect, with production of the IVa2
protein leading to synthesis of structural proteins via
stimulation of ML transcription. The consequences or
biological significance of this difference in regulation of
the expression of papavo- and adeno-viral late gene
products are not yet clear. Identification of the protein(s)
comprising IVa2-RF, and of the second, infected cell-
specific protein that cooperates with the IVa2 protein to
nduce the dramatic increase in the efficiency of ML
ranscription characteristic of the late phase of infection
see Introduction) might provide some insight into this
ssue.
MATERIALS AND METHODS
ells and virus
HeLa cells were maintained in suspension culture in
MEM (Gibco BRL) containing 5% calf serum, and HAV-2
as propagated in these cells as described (Flint et al.,
975). The titer of virus stocks was determined by plaque
ssay on HeLa cell monolayers (Williams, 1973).
onstruction of mutant IVa2 templates
The wild-type IVa2 template, pIVa2-ML, for the majority
f experiments reported here comprised the HAV-2 DNA
ragment spanning positions 2405 to 1180 of the IVa2
transcription unit in plasmid pUC19. This template there-
fore also contained the ML promoter, which directs tran-
scription from the opposite strand of the viral genome
(see Fig. 1). Precise substitutions were introduced be-
tween positions 110 and 120 of the IVa2 promoter, the
sequence that comprises the 59 two-thirds of the previ-
usly identified binding site for IVa2-RF (Fig. 1; Chen et
al., 1994), by the unique site elimination method (Deng
and Nicholson, 1992). The presence of the desired mu-
tation, but absence of any other change, in the HAV-2
DNA segment, was confirmed by sequencing all mutant
DNAs (Sanger et al., 1977). A minimal IVa2 promoter
consisting of the sequence 29 to 131 in pUC19 and a
mutant derivative carrying a precise 6-bp substitution
within the center of the IVa2-RF-binding site, in plasmids
pIVInr-TC and pIVa2-dsm2, respectively (Chen et al.,
1994), were used in some experiments. Plasmid DNAs to
be used as templates in in vitro transcription reactions
were prepared and purified as described previously
(Chen et al., 1994). The quality and quantity of templates
were checked by electrophoresis in 1.4% agarose gels
cast and run in 0.098 M Tris–borate buffer, pH 8.3, con-
taining 2 mM EDTA (13 TBE) followed by ethidium bro-
mide staining.Preparation of cell extracts and separation of IVa2-RF
rom proteins necessary for basal transcription
Whole HeLa cell extracts were prepared from actively
rowing HeLa cells by the modification of the method of
anley et al. (1980) described previously (Leong and
lint, 1984). For comparison of the transcriptional activi-
ies of uninfected and HAV-2-infected cell extracts, HeLa
ells were infected at 15 PFU/ml, or mock-infected, and
arvested 12–16 h after infection. Extracts were then
repared in parallel. Protein concentrations were deter-
ined by the method of Bradford (1978). For partial pu-
ification of IVa2-RF, whole-cell extracts from 20–30 L
freshly harvested HeLa cells were fractionated on Af-
figel–heparin–agarose (Bio-Rad) by a modification of a
protocol described previously (Chen et al., 1994). The
column was preequilibrated and loaded in 20 mM
HEPES–KOH, pH 7.4, containing 5 mM MgCl2, 0.1 mM
EDTA, 2 mM DTT, 20% glycerol, 1 mM PMSF, and 1 mg/ml
ach of antipain, pepstatin, and leupeptin (buffer A), and
.1 M KCl, and IVa2-RF eluted with 0.18 M KCl in the same
buffer. This heparin–agarose fraction was then passed
over DEAE–cellulose preequilibrated and loaded in
buffer A containing 0.2 M KCl, conditions under which
IVa2-RF did not bind. The flow-through fraction was di-
uted with an equal volume of buffer A and IVa2-RF was
oncentrated by binding to and elution from a small (;2
l) heparin–agarose column as described above. Fol-
owing elution with buffer A containing 0.18 M KCl, the
riginal heparin–agarose column was eluted with buffer
containing 1.0 M KCl. This fraction was used as a
ource of RNA polymerase II and other proteins neces-
ary for transcription from the IVa2 and ML promoters. All
fractions to be used in in vitro transcription and DNA-
binding assays were dialyzed into buffer A containing 0.1
M KCl, divided into small portions, and stored at 280°C.
lectrophoretic mobility shift assays
The DNA-binding activity of partially purified IVa2-RF,
or IVa2-RF present in whole-cell extracts, was examined
by an electrophoretic mobility shift assay with a 32P-
labeled DNA fragment corresponding to positions 12 to
135 of the HAV-2 IVa2 transcription unit, as described
previously (Chen et al., 1994). Mutant DNAs used as
competitors were prepared by annealing complemen-
tary, synthetic oligonucleotides containing the mutations
that were introduced into IVa2 transcriptional templates
(Kasai et al., 1992). The quantities of specific complex
formed in the absence and presence of wild-type and
mutant competitor DNAs were measured using a Molec-
ular Dynamics phosphorimager.
In vitro transcription assaysStandard transcription reactions contained 6 mg/ml
whole-cell-extract protein, 4.2 mg/ml of the internal con-
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409A CELLULAR REPRESSOR OF IVa2 TRANSCRIPTIONtrol template pML(C2AT)D-50 comprising the HAV-2 ML
promoter from positions 250 to 110 linked to a G-less
cassette (Sawadogo and Roeder, 1985a), 8.3 mg/ml tem-
late DNA, 12 mM HEPES–KOH, pH 7.9, 67 mM KCl, 6.7
M MgCl2, a 0.6 mM concentration each of ATP, CTP,
TP, and UTP, 10% glycerol, and 2 mM DTT in a total
olume of 30 ml. Transcription by uninfected cell proteins
eparated from IVa2-RF by chromatography on heparin–
agarose was assayed in identical fashion, except that
reactions contained proteins of the 1.0 M KCl eluate from
the column. Reactions were incubated at 30°C for 60
min, and transcripts were purified and analyzed by
primer extension as described (Kasai et al., 1992). Prim-
ers for detection of IVa2 and ML transcripts of the
pIVa2-ML templates were complementary to positions
40 to 165 and positions 115 to 140, respectively, of
hese transcription units. The quantities of cDNAs were
etermined using a Molecular Dynamics phosphorim-
ger.
ACKNOWLEDGMENTS
We thank H. Chen for performing experiments to compare IVa2
transcription in uninfected and HAV-2-infected cell extracts, and Jana
Kiefer for excellent technical assistance. This work was supported by
a grant from the National Institutes of Health.
REFERENCES
Adami, G., and Babiss, L. E. (1992). Evidence that USF can interact with
only a single general transcription complex at one time. Mol. Cell.
Biol. 12, 1630–1638.
Akusja¨rvi, G., and Persson, H. (1981). Controls of RNA splicing and
termination in the major late adenovirus transcription unit. Nature
292, 420–426.
Alonso-Caplen, F. V., Katze, M. G., and Krug, R. M. (1988). Efficient
transcription not translation is dependent on adenovirus tripartite
leader sequences at late times of infection. J. Virol. 62, 1606–1616.
Bartek, J., Bartkova, J., and Lukas, J. (1996). The retinoblastoma protein
pathway and the restriction point. Curr. Opin. Cell. Biol. 8, 805–814.
Berk, A. J. (1986). Adenovirus promoters and E1A transactivation. Annu.
Rev. Genet. 20, 45–79.
Berk, A. J., Lee, F., Harrison, T., Williams, J. F., and Sharp, P. A. (1979). A
pre-early adenovirus 5 gene product regulates synthesis of early
viral messenger RNAs. Cell 17, 935–944.
Binger, M. H., and Flint, S. J. (1984). Accumulation of early and inter-
mediate mRNA species during subgroup C adenovirus productive
infections. Virology 136, 387–403.
Boyer, T. G., Martin, M. E., Lees, E., Ricciardi, R. P., and Berk, A. J. (1999).
Mammalian Srb/Mediator complex is targeted by adenovirus E1A
protein. Nature 399, 276–279.
Bradford, N. N. (1976). A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of protein-
dye binding. Anal. Biochem. 72, 248–254.
Carcamo, J., Buckbinder, L., and Reinberg, D. (1991). The initiator directs
assembly of a transcription factor IID-dependent complex. Proc. Natl.
Acad. Sci. USA 88, 8052–8056.
Carcamo, J., Lobos, S., Merino, A., Buckbinder, L., Weinmann, R., Nat-
arajan, V., and Reinberg, D. (1989). Factors involved in specific tran-
scription by mammalian RNA polymerase II. Role of factors IID and
MLTF in transcription from the adenovirus major late and IVa2 pro-
moters. J. Biol. Chem. 264, 7704–7714.
Chen, H., and Flint, S. J. (1992). Mutational analysis of the adenovirus 2IVa2 initiator and downstream elements. J. Biol. Chem. 267, 25457–
25465.
Chen, H., Vinnakota, R., and Flint, S. J. (1994). Intragenic activating and
repressing elements control transcription from the adenovirus IVa2
initiator. Mol. Cell. Biol. 14, 676–685.
Chiang, C.-M., and Roeder, R. G. (1995). Cloning of an intrinsic human
TFIID subunit that interacts with multiple transcriptional activators.
Science 267, 531–536.
Chodosh, L. A., Carthew, R. W., and Sharp, P. A. (1986). A single
polypeptide possesses the binding and transcription activities of the
adenovirus major late transcription factor. Mol. Cell. Biol. 6, 4723–
4733.
Chow, L. T., Broker, T. R., and Lewis, J. (1979). Complex splicing patterns
of RNAs from the early region of adenovirus-2. J. Mol. Biol. 134,
265–303.
Crossland, L. D., and Raskas, H. J. (1983). Identification of adenovirus
genes that require template replication for expression. J. Virol. 46,
737–748.
Deng, W. P., and Nicholson, J. A. (1992). Site-directed mutagenesis of
virtually any plasmid by eliminating a unique site. Anal. Biochem.
200, 81–88.
Dou, S., Zeng, X., Cortes, P., Erdjument-Bromage, H., Tempst, P., Honjo,
T., and Vales, L. D. (1994). The recombination signal sequence-
binding protein RBP-2N functions as a transcriptional repressor. Mol.
Cell. Biol. 14, 3310–3319.
ynan, W. S., and Tjian, R. (1983). The promoter-specific transcription
factor Sp1 binds to upstream sequences in the SV40 early promoter.
Cell 35, 79–87.
Flint, J., and Shenk, T. (1997). Viral transactivating proteins. Ann. Rev.
Genet. 31, 177–212.
Flint, K. J., and Jones, N. C. (1991). Differential regulation of three
members of the ATF/CREB family of DNA-binding proteins. Onco-
gene 6, 2019–2026.
Flint, S. J. (1986). Regulation of adenovirus mRNA formation. Adv. Virus
Res. 31, 169–228.
Flint, S. J., Gallimore, P. H., and Sharp, P. A. (1975). Comparison of viral
RNA sequences in adenovirus 2-transformed and lytically infected
cells. J. Mol. Biol. 96, 47–68.
Fraser, N. W., Nevins, J. R., Ziff, E., and Darnell, J. E. J. (1979). The major
late adenovirus type-2 transcription unit: Termination is downstream
from the last poly(A) site. J. Mol. Biol. 129, 643–656.
Geisberg, J. V., Chen, J. L., and Ricciardi, R. P. (1995). Subregions of the
adenovirus E1A transactivation domain target multiple components
of the TFIID complex. Mol. Cell. Biol. 15, 6283–6290.
Geisberg, J. V., Lee, W. S., Berk, A. J., and Ricciardi, R. P. (1994). The zinc
finger region of the adenovirus E1A transactivating domain com-
plexes with the TATA box binding protein. Proc. Natl. Acad. Sci. USA
91, 2488–2492.
Griffin, B. (1980). Structure and genomic organization of SV40 and
polyoma virus. In “DNA Tumor Viruses, Molecular Biology of Tumor
Viruses” (J. Tooze, Ed.), 2nd ed., Part 2, pp. 61–123. Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY.
Gustin, K., Lutz, P., and Imperiale, M. (1996). Interaction of the adeno-
virus L1 52/55-kilodalton protein with the IVa2 gene product during
infection. J. Virol. 70, 6463–6467.
wamoto, S., Eggerding, F., Falck-Pederson, E., and Darnell, J. E., Jr.
(1986). Transcription unit mapping in adenovirus: Regions of termi-
nation. J. Virol. 59, 112–119.
ansen-Durr, P., Boeuf, H., and Kedinger, C. (1988). Replication-induced
stimulation of the major late promoter of adenovirus is correlated to
the binding of a factor to sequences in the first intron. Nucleic Acids
Res. 16, 3771–3786.
ansen-Durr, P., Monde´sert, G., and Kedinger, C. (1989). Replication-
dependent activation of the adenovirus major late promoter is me-
diated by the increased binding of a transcription factor to se-
quences in the first intron. J. Virol. 63, 5124–5132.
LL
L
M
M
M
M
M
M
M
M
V
410 LIN AND FLINTJones, N. (1995). Transcriptional modulation by the adenovirus E1A
gene. Curr. Top. Microbiol. Immunol. 199, 59–80.
Jones, N., and Shenk, T. (1979). An adenovirus type 5 early gene
function regulates expression of other early viral genes. Proc. Natl.
Acad. Sci. USA 76, 3665–3669.
Kasai, Y., Chen, H., and Flint, S. J. (1992). Anatomy of an unusual RNA
polymerase II promoter containing a downstream TATA element. Mol.
Cell. Biol. 12, 2884–2897.
Kovesdi, I., Reichel, R., and Nevins, J. R. (1986a). E1A transcription
induction: Enhanced binding of a factor to upstream promoter se-
quences. Science 231, 719–722.
Kovesdi, I., Reichel, R., and Nevins, J. R. (1986b). Identification of a
cellular transcription factor involved in E1A trans-activation. Cell 45,
219–228.
Larsson, S., Svensson, C., and Akusja¨rvi, G. (1992). Control of adeno-
virus major late gene expression at multiple levels. J. Mol. Biol. 225,
287–298.
Lee, W. C., Kao, C. C., Bryant, G. O., Liu, X., and Berk, A. J. (1991).
Adenovirus E1A activation domain binds the basic repeat in the TATA
box transcription factor. Cell 67, 365–376.
eong, K., Brunet, L., and Berk, A. J. (1988). Factors responsible for the
higher transcriptional activation of extracts of adenovirus infected
cells fractionate with the TATA box transcription factor. Mol. Cell. Biol.
8, 1765–1774.
eong, K., and Flint, S. J. (1984). Specific transcription of an adenoviral
gene that possesses no TATA sequence homology in extracts of
HeLa cells. J. Biol. Chem. 259, 11527–11533.
eong, K., Lee, W., and Berk, A. J. (1990). High level transcription from
the adenovirus major late promoter requires downstream binding
sites for late-phase-specific factors. J. Virol. 64, 51–60.
Liu, F., and Green, M. R. (1990). A specific member of the ATF tran-
scription factor family can mediate transcription activation by the
adenovirus E1a protein. Cell 61, 1217–1224.
Lutz, P., and Kedinger, C. (1996). Properties of the adenovirus IVa2 gene
product, an effector of late phase-dependent activation of the major
late promoter. J. Virol. 70, 1396–1405.
anohar, C. F., Kratochvil, J., and Thimmappaya, B. (1990). The adeno-
virus EII early promoter has multiple E1A-sensitive elements, two of
which function cooperatively in basal and virus-induced transcrip-
tion. J. Virol. 64, 2457–2466.
ansour, S. L., Grodzicker, T., and Tjian, R. (1986). Downstream se-
quences affect transcription initiation from the adenovirus major late
promoter. Mol. Cell. Biol. 6, 2684–2694.
ason, B. B., Davis, A. R., Bhat, B. M., Chengalvala, M., Lubeck, M. D.,
Zandle, G., Kostek, B., Cholodofsky, S., Dheer, S., Molnar-Kimber, K.,
et al. (1990). Adenovirus vaccine vectors expressing hepatitis B
surface antigen: Importance of regulatory elements in the adenovirus
major late intron. Virology 177, 452–461.
atsui, T. (1982). In vitro accurate initiation of transcription on the
adenovirus type 2 IVa2 gene which does not contain a TATA box.
Nucleic Acids Res. 10, 7089–7101.
Mazzarelli, J. M., Mengus, G., Davidson, I., and Ricciardi, R. P. (1997).
The transactivation domain of adenovirus E1A interacts with the C
terminus of human TAF(II)135. J. Virol. 71, 7978–7983.
iyamoto, N. G., Moncolin, V., Egly, J. M., and Chambon, P. (1985).
Specific interaction between a transcription factor and the upstream
element of the adenovirus-2 major late promoter. EMBO J. 4, 3563–
3570.
oncollin, V., Kempf, A., and Egly, J. M. (1990). The mammalian up-
stream element factor recognizes two sites in the adenovirus type 2
IVa2-major late promoter intergenic region and stimulates both pro-
moters. J. Virol. 64, 3199–3206.
onde´sert, G., Tribouley, C., and Kedinger, C. (1992). Identification of a
novel downstream binding protein implicated in late-phase-specific
activation of the adenovirus major late promoter. Nucleic Acids Res.
20, 3881–3889.oran, E., and Mathews, M. B. (1987). Multiple functional domains in
the adenovirus E1A gene. Cell 48, 177–178.
Natarajan, V., Madden, M. J., and Salzman, N. P. (1983). Preferential
stimulation of transcription from simian virus 40 late and adeno IVa2
promoters in a HeLa cell extract. J. Biol. Chem. 258, 14652–14655.
Natarajan, V., Madden, M. J., and Salzman, N. P. (1984). Proximal and
distal domains that control in vitro transcription of the adenovirus
IVa2 gene. Proc. Natl. Acad. Sci. USA 81, 6290–6294.
Natarajan, V., and Salzman, N. P. (1985). Cis and trans activation of
adenovirus IVa2 gene transcription. Nucleic Acids Res. 13, 4067–
4083.
Nevins, J. R. (1981). Mechanism of activation of early viral transcription
by the adenovirus E1A gene product. Cell 26, 213–220.
Nevins, J. R. (1992). E2F: A link between the Rb tumor suppressor
protein and viral oncoproteins. Science 258, 424–429.
Persson, H., Mathisen, B., Philipson, L., and Pettersson, U. (1979). A
maturation protein in adenovirus morphogenesis. Virology 93, 198–
208.
Reach, M., Babiss, L. E., and Young, C. S. H. (1990). The upstream
factor-binding site is not essential for activation of transcription from
the adenovirus major late promoter. J. Virol. 64, 5851–5860.
Roovers, D. J., Overman, P. F., Chen, X.-Q., and Sussenbach, J. S. (1991).
Linker mutation scanning of the gene encoding the adenovirus type
5 terminal protein precursor and DNA polymerase. Virology 180,
273–284.
Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with
chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463–
5467.
Sawadogo, M., and Roeder, R. G. (1985a). Factors involved in specific
transcription by human RNA polymerase II: Analysis by a rapid and
quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82, 4394–4398.
Sawadogo, M., and Roeder, R. G. (1985b). Interaction of a gene-specific
transcription factor with the adenovirus major late promoter up-
stream of the TATA box region. Cell 43, 165–175.
Shaw, A. R., and Ziff, E. B. (1980). Transcripts from the adenovirus-2
major late promoter yield a single early family of 39 co-terminal
mRNAs and five late families. Cell 22, 905–916.
Shenk, T. (1996). Adenoviridae and their replication. In “Virology” (B.
Fields, P. Howley, and D. Knipe, Ed.), pp. 2111–2148. Raven Press,
New York.
Shenk, T., and Flint, S. J. (1991). Transcriptional and transforming activ-
ities of the adenovirus E1A proteins. Adv. Cancer Res. 57, 47–83.
Thomas, G. B., and Mathews, M. B. (1980). DNA replication and the
early to late transition in adenovirus infection. Cell 22, 523–533.
Tribouley, C., Lutz, P., Staub, A., and Kedinger, C. (1994). The product of
the adenovirus intermediate gene IVa2 is a transcription activator of
the major late promoter. J. Virol. 68, 4450–4457.
ales, L. D., and Darnell, J. E. (1989). Promoter occlusion prevents
transcription of adenovirus polypeptide 13 mRNA until after DNA
replication. Genes Dev. 3, 49–59.
Weinberg, R. (1995). The retinoblastoma protein and cell cycle control.
Cell 81, 323–330.
Wiley, S. R., Kraus, R. J., Zuo, F., Murray, E. E., Lovitz, K., and Mertz, J. E.
(1993). SV40 early-to-late switch involves titration of cellular tran-
scriptional repressor. Genes Dev. 7, 2206–2219.
Williams, J. F. (1973). Oncogenic transformation of hamster embryo cells
in vitro by adenovirus type 5. Nature 243, 162–163.
Winter, N., and D’Halluin, D. J. (1991). Regulation of the biosynthesis of
subgroup C adenovirus protein IVa2. J. Virol. 65, 5250–5259.
Zajchowski, D. A., Boeuf, H., and Kedinger, C. (1985). The adenovirus-2
early EIIa transcription unit possesses two overlapping promoters
with different sequence requirements for E1a-dependent stimulation.
EMBO J. 4, 1293–1300.Zhang, W., and Imperiale, M. J. (2000). Interaction of the adenovirus IVa2
protein with viral packaging sequences. J. Virol. 74, 2687–2693.
